A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case-control studies

被引:15
|
作者
Hosono, Satoyo [1 ]
Ito, Hidemi [1 ,5 ]
Oze, Isao [1 ]
Watanabe, Miki [1 ]
Komori, Koji [3 ]
Yatabe, Yasushi [4 ]
Shimizu, Yasuhiro [3 ]
Tanaka, Hideo [1 ,5 ]
Matsuo, Keitaro [2 ]
机构
[1] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan
[2] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi, Japan
[3] Aichi Canc Ctr Hosp, Dept Gastroenterol Surg, Nagoya, Aichi, Japan
[4] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan
[5] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Nagoya, Aichi, Japan
关键词
case-control studies; colorectal cancer; genetic polymorphism; genome-wide association study; Japanese; risk assessment; FOOD FREQUENCY QUESTIONNAIRE; COLON-CANCER; GENERAL-POPULATION; SUSCEPTIBILITY; MORTALITY; LOCUS; SMAD7;
D O I
10.1097/CEJ.0000000000000213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Most genome-wide association studies of colorectal cancer (CRC) carried out to date have been in populations with European ancestry, and the extent to which the identified variants contribute as predictors of CRC among Japanese populations has not been clarified. We analyzed 23 genetic variants identified in previous genome-wide association studies in a derivation case-control study with 558 cases and 1116 age-matched and sex-matched controls. Six single nucleotide polymorphisms were selected for synthesis of the genetic risk score. A dose-dependent association was observed between CRC risk and genetic risk score, which is the aggregate number of alleles in six selected variants: 8q24 - rs6983267, 15q13 - rs4779584 and rs1696961, 14q22 - rs444435, 16q22 - rs9929218, and 3q26.2 - rs1093599. The c statistic for a model that included the genetic risk score and conventional risk factors was 0.7167, versus 0.7009 with the conventional risk factors only (P=0.0013). This model was evaluated in a replication study with 547 cases and 547 age-matched and sex-matched controls, and the corresponding c statistics were 0.6356 and 0.6391 with no statistical significance. When the two studies were combined, the corresponding c statistics were 0.6132 and 0.6198 (P=0.0126). We developed a risk model that incorporates a genetic risk score and established risk factors, but this model was not satisfactory in the replication study. The results in the combined study still encourage further attempts using a similar approach among individual countries.
引用
收藏
页码:500 / 507
页数:8
相关论文
共 50 条
  • [11] A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study
    Schmit, Stephanie L.
    Schumacher, Fredrick R.
    Edlund, Christopher K.
    Conti, David V.
    Raskin, Leon
    Lejbkowicz, Flavio
    Pinchev, Mila
    Rennert, Hedy S.
    Jenkins, Mark A.
    Hopper, John L.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Le Marchand, Loic
    Gallinger, Steven
    Haile, Robert W.
    Newcomb, Polly A.
    Huang, Shu-Chen
    Rennert, Gad
    Casey, Graham
    Gruber, Stephen B.
    CARCINOGENESIS, 2014, 35 (11) : 2512 - 2519
  • [12] Genome-wide analysis of spina bifida risk variants in a case-control study from Bangladesh
    Tindula, Gwen
    Issac, Biju
    Mukherjee, Sudipta Kumer
    Ekramullah, Sheikh Muhammad
    Arman, D. M.
    Islam, Joynul
    Suchanda, Hafiza Sultana
    Sun, Liang
    Rockowitz, Shira
    Christiani, David C.
    Warf, Benjamin C.
    Mazumdar, Maitreyi
    BIRTH DEFECTS RESEARCH, 2024, 116 (03):
  • [13] Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies
    Liu, Caiyang
    Cui, Huijie
    Gu, Dongqing
    Zhang, Min
    Fang, Yanfei
    Chen, Siyu
    Tang, Mingshuang
    Zhang, Ben
    Chen, Huanwen
    LUNG CANCER, 2017, 113 : 18 - 29
  • [14] Chronic Constipation as a Risk Factor for Colorectal Cancer: Results From a Nationwide, Case-Control Study
    Staller, Kyle
    Olen, Ola
    Soderling, Jonas
    Roelstraete, Bjorn
    Tornblom, Hans
    Song, Mingyang
    Ludvigsson, Jonas F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1867 - +
  • [15] Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies
    Jie Tian
    Guanchu Liu
    Chunjian Zuo
    Caiyang Liu
    Wanlun He
    Huanwen Chen
    Cancer Biology & Medicine, 2019, (02) : 361 - 376
  • [16] Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies
    Peng, Sihua
    Lue, Bingjian
    Ruan, Wenjing
    Zhu, Yimin
    Sheng, Hongqiang
    Lai, Maode
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 309 - 324
  • [17] Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies
    Tian, Jie
    Liu, Guanchu
    Zuo, Chunjian
    Liu, Caiyang
    He, Wanlun
    Chen, Huanwen
    CANCER BIOLOGY & MEDICINE, 2019, 16 (02) : 361 - +
  • [18] Colorectal Cancer Risk Factors among the Population of South-East Siberia: A Case-Control Study
    Zhivotovskiy, Alexey S.
    Kutikhin, Anton G.
    Azanov, Artur Z.
    Yuzhalin, Arseniy E.
    Magarill, Yuri A.
    Brusina, Elena B.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5183 - 5188
  • [19] Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study
    Rudolph, Anja
    Shi, Hong
    Foersti, Asta
    Hoffmeister, Michael
    Sainz, Juan
    Jansen, Lina
    Hemminki, Kari
    Brenner, Hermann
    Chang-Claude, Jenny
    BMC CANCER, 2014, 14
  • [20] Association between ICOS polymorphisms and risk of colorectal cancer: a case-control study involving 2,606 subjects
    Jiang, Jiakai
    Tang, Weifeng
    Liu, Chao
    Wang, Yafeng
    Zhang, Sheng
    Chen, Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2822 - 2830